Phenobarbital during pregnancy in mouse and man

Area of Science:

• Pharmacology
• Neuroscience
• Reproductive Toxicology

Background:

• Phenobarbital (PB) demonstrates dose-dependent behavioral effects, causing excitation at low doses and sedation at higher doses in both mice and humans.
• Brain concentrations of phenobarbital at excitation and depression thresholds show minimal species-specific differences, though higher doses are required in mice.
• Pregnancy is associated with declining phenobarbital plasma concentrations in humans and rodents, with controversial implications for seizure frequency and drug efficacy.

Purpose of the Study:

• To compare phenobarbital's behavioral effects and brain concentrations across species.
• To investigate the impact of pregnancy on phenobarbital levels and efficacy.
• To evaluate the effects of phenobarbital on pregnancy progression and offspring in animal models.

Main Methods:

• Behavioral studies in mice and humans to assess dose-response relationships.
• Pharmacokinetic analysis of phenobarbital plasma and brain concentrations during pregnancy in rodents.
• Controlled administration of phenobarbital to pregnant rodents via diet or injection to assess developmental and neonatal outcomes.

Main Results:

• Phenobarbital induces similar excitation and depression effects in mice and humans at comparable brain concentrations.
• Rodent studies confirm reduced phenobarbital plasma levels during pregnancy, with conflicting reports on brain concentrations and drug potency.
• Dietary administration of phenobarbital in rodents leads to adverse effects on offspring, including low birth weight and abnormalities, potentially confounded by nutritional deficits.
• Injectable phenobarbital in rodents shows dose-dependent effects on pregnancy, with higher doses increasing neonatal mortality and reducing offspring body weight and behavior, even at therapeutically relevant levels.

Conclusions:

• Phenobarbital's behavioral effects are conserved across species, but species-specific dosing is necessary.
• The impact of pregnancy on phenobarbital efficacy remains unclear, necessitating further research.
• Phenobarbital exposure during gestation in rodents can lead to significant adverse outcomes in offspring, highlighting the need for careful management during pregnancy.